Neuropeptide Y in anxiety and alcoholism

被引：0
|
作者：
Heilig, M [1 ]
机构：
[1] NIAAA, NIH, Bethesda, MD USA
来源：
BEHAVIOURAL PHARMACOLOGY | 2005年 / 16卷
关键词：
D O I：
10.1097/00008877-200509001-00011
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Neuropeptide Y in anxiety and alcoholism
    Heilig, M
    FASEB JOURNAL, 2006, 20 (04): : A416 - A416
  • [2] Neuropeptide Y in stress, anxiety, and alcoholism
    Thorsell, Annika
    Cippitelli, Andrea
    Heilig, Markus
    ALCOHOL, 2008, 42 (04) : 310 - 310
  • [3] Epigenetic and signaling mechanisms of neuropeptide Y regulation in the amygdala: Role in Anxiety and Alcoholism
    Pandey, Subhash C.
    ALCOHOL, 2014, 48 (02) : 162 - 163
  • [4] Neuropeptide Y and alcoholism: Genetic, molecular, and pharmacological evidence
    Pandey, SC
    Carr, LG
    Heilig, M
    Ilveskoski, E
    Thiele, TE
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 27 (02) : 149 - 154
  • [5] Neuropeptide Y: The Light Side of the Dark Side of Alcoholism
    Gilpin, Nicholas W.
    ALCOHOL, 2011, 45 (03) : 279 - 279
  • [6] Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y
    Bowers, Mallory E.
    Choi, Dennis C.
    Ressler, Kerry J.
    PHYSIOLOGY & BEHAVIOR, 2012, 107 (05) : 699 - 710
  • [7] Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala
    Sajdyk, TJ
    Schober, DA
    Smiley, DL
    Gehlert, DR
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (03) : 419 - 423
  • [8] Neuropeptide Y (NPY) in anxiety, depression and alcohol dependence
    Heilig, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S172 - S172
  • [9] Neuropeptide Y receptors as therapeutic targets in anxiety and depression
    Sajdyk, TJ
    DRUG DEVELOPMENT RESEARCH, 2005, 65 (04) : 301 - 308
  • [10] Central functions of neuropeptide Y in mood and anxiety disorders
    Wu, Gang
    Feder, Adriana
    Wegener, Gregers
    Bailey, Christopher
    Saxena, Shireen
    Charney, Dennis
    Mathe, Aleksander A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (11) : 1317 - 1331
12345